China Life Equity Investment
Profile, fund size and portfolio
China Life Equity Investment is the corporate venture arm of China Life Insurance, an insurance company. It was founded in 2016 and is based in Shanghai, China. It invests from Series B to Series C+. Sectors it names: healthcare and digital health, biotech and life sciences, artificial intelligence.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series B to Series C+ |
| Sectors | Healthcare and digital health, Biotech and life sciences, Artificial intelligence |
| Geography | Asia |
| Offices | Shanghai, China, Beijing, China |
Sources: S3 China Life Private Equity news center; S1 China Life Equity Investment about.
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | CNY 10bn | Fund size | Stated by the firm or its parent | S1 |
| Companies backed | 11+ | companies | Stated by the firm | S1 |
| Companies on the firm's portfolio page | 18 | companies | Counted from the firm's own list | S2 |
Sources: S1 China Life Equity Investment about; S2 China Life Equity Investment home and news.
Where it invests and who leads it
LeadersS5
- Zhang Leidi (张蕾娣)Managing Director and member of the management committee, China Life Private Equity InvestmentFind on LinkedIn
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | China Life Insurance (SSE: 601628) | Single source | S1 |
| Parent industry | Insurance | Single source | S1 |
| Founded | 2016 | Single source | S1 |
| Headquarters | Shanghai, China | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent and outside investors | Single source | S1 |
| Headline size | CNY 10bn (Fund size) | Single source | S1 |
| Companies backed | 11+ | Single source | S1 |
| Stages | Series B, Series C+ (inferred from announced rounds) | Estimate | S3 |
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
| Company | Type | Year | Acquirer or exchange | Source |
|---|---|---|---|---|
| 百奥赛图 | IPO | 2022 | Hong Kong Stock Exchange | S3 |
| 奥浦迈 | IPO | 2022 | STAR Market | S3 |
| 联影医疗 | IPO | 2022 | STAR Market | S3 |
| 健世科技 | IPO | 2022 | Hong Kong Stock Exchange | S3 |
| 普瑞眼科 | IPO | 2022 | ChiNext | S3 |
| 第四范式 | IPO | 2023 | Hong Kong Stock Exchange | S3 |
| 晶泰科技 | IPO | 2024 | Hong Kong Stock Exchange | S3 |
| 赛分科技 | IPO | 2025 | STAR Market | S3 |
| 汉邦科技 | IPO | 2025 | STAR Market | S3 |
| 西安奕材 | IPO | 2025 | STAR Market | S3 |
Recent rounds
| Date | Company | Round | Amount | Led by the firm | Source |
|---|---|---|---|---|---|
| 2023-07-05 | 海辰储能 | Series C+ | Not stated | Yes | S3 |
| 2023-06-14 | 关怀医疗 | Series C+ | Not stated | Yes | S3 |
| 2023-06-01 | 盈科生物 | Series B | Not stated | Yes | S3 |
| 2023-05-22 | 伟杰信生物 | Series C+ | Not stated | Yes | S3 |
| 2023-03-09 | 视微影像 | Series C+ | Not stated | Yes | S3 |
| 2023-01-09 | 芯长征科技 | Series C+ | Not stated | Yes | S3 |
| 2022-07-20 | 迈科康生物 | Not stated | Not stated | Yes | S3 |
Fund vehicles
Portfolio
The firm's portfolio page lists 18 companies.S2
The firm also states 11+ companies backed. The page list and the stated total measure different things.S1
Every company on the China Life Equity Investment list
18 companies, as listed on the firm's own website.S2 Read the firm's list.
- 4Paradigm
- Black Sesame Technologies
- BrainCo
- Care Medical
- Huisheng Biotech
- Innovent Biologics
- Mindray
- Shining3D
- United Imaging Healthcare
- WuXi AppTec
- XtalPi
- 伟杰信生物
- 关怀医疗
- 海辰储能
- 盈科生物
- 芯长征科技
- 视微影像
- 迈科康生物
History
- Established in June 2016 in the Shanghai free trade zoneS1
- China Life Private Equity Investment established in June 2016 in the Shanghai Free Trade Zone; China Life Healthcare Fund launched in November 2016.S2
- Portfolio company Biocytogen (百奥赛图) listed on the STAR Market in December 2025, after its 2022 Hong Kong listing.S3
About China Life Insurance
Official pages
Read the firm's own pages for current information.
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by China Life Equity Investment or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.